Please select the option that best describes you:
Topics:
Infectious Disease • Critical Care • General Infectious Disease • Hospital Medicine • Primary Care • Urgent Care • General Primary Care • General Hospital Medicine
When do you recommend limited or targeted respiratory pathogen testing versus a full respiratory pathogen panel in a patient presenting with URI symptoms?
In other words, are there benefits to identifying URI pathogens that do not necessarily have targeted therapies (e.g., rhinovirus, non-COVID-19 Coronavirus, human metapneumovirus, etc.)?
Answer from: at Academic Institution
Guidelines recommend not sending full RVP (since it almost never changes management) for floor-level patients, unless immunocompromised.
Sign in or Register to read more
Answer from: at Academic Institution
For this question, I start with several factors in mind: how sick is the patient, where is the clinical encounter taking place (office vs inpatient hospital vs ICU), what are the patient specific risk factors that would put them at risk for more severe disease, and how does the testing impact treatm...